The mutagenic potential of the furylethylene derivative 2-furyl-1-nitroethene in the mouse bone marrow micronucleus test

Toxicological Sciences

Volumn 72, Issue 2, 2003, Pages 359-362

  González Borroto, Jorge I ^a,b   Creus, Amadeu ^a   Marcos, Ricard ^a   Mollà, Ricard ^b   Zapatero, Jorge ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Ctr Invest y Desarrollo Aplicado   (Spain)

Author keywords

Bone marrow; Furylethylenes; Mice; Micronucleus assay; Polychromatic erythrocytes

Indexed keywords

ANEUGEN; CLASTOGEN; CORN OIL; CYCLOPHOSPHAMIDE; ETHYLENE DERIVATIVE; NITROFURAN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; BONE MARROW TOXICITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG STRUCTURE; ERYTHROCYTE; GENETIC TOXICOLOGY; IN VIVO STUDY; MALE; MICRONUCLEUS TEST; MOUSE; MOUSE STRAIN; MUTAGENICITY; NONHUMAN; SAMPLING; SENSITIVITY ANALYSIS; STATISTICAL SIGNIFICANCE; STRUCTURE ACTIVITY RELATION; TOXICITY TESTING;

ANIMALS; BONE MARROW CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROBLASTS; FURANS; MALE; MICE; MICE, INBRED STRAINS; MICRONUCLEUS TESTS; MUTAGENS; NITRO COMPOUNDS;

ANIMALIA; ZEA MAYS;

EID: 0346599191     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfg038     Document Type: Article

References (22)

1. Crebelli, R., Carere, A., Leopardi, P., Conti, L., Fassio, F., Raiteri, F., Barone, D., Ciliutti, P., Cinelli, S., and Vericat, J. A. (1999). Evaluation of 10 aliphatic halogenated hydrocarbons in the mouse bone-marrow micronucleus test. Mutagenesis 2, 207-215.
2. Estrada, E. (1998). Structure-mutagenicity relationships in 2-furylethylene derivatives. A molecular orbital study of the role of nitro groups. Mutat. Res. 420, 67-75.
3. European Union (1992). Commission Directive 92/69/EEC, Annex V B12. Off. J. Eur. Community 35, 154-156.
4. Gajewska, J., Szczypka, M., Tudek, B., and Szymczyk, T. (1990). Studies on the effect of ascorbic acid and selenium on the genotoxicity of nitrofurans: Nitrofarazone and furazolidone. Mutat. Res. 232, 191-197.
5. González Borroto, J. G., Creus, A., and Marcos, R. (2001). Genotoxic evaluation of the furylethylene derivative 2-furyl-1-nitroethene in cultured human lymphocytes. Mutat. Res. 497, 177-184.
6. González Borroto, J. G., Creus, A., and Marcos, R. (2002). Genotoxic evaluation of the furylethylene derivative 1-(5-bromofur-2-yl)-2-nitroethene in cultured human lymphocytes. Mutat. Res. 519, 179-185.
7. Hamilton-Miller, J. M. T. (1997). Nitrofurans. In Antibiotic and Chemotherapy, 7th ed. (F. O'Grady, H. P. Lambert, R. G. Finch, and D. Greenwood, Eds.), pp. 396-403. Churchill Livingstone, London.
8. Hatcher, J. F., Yamamoto, K., Ichikawa, M., Bryan, G. T., and Swaminathan, S. (1995). Metabolic reduction of novel 3,4-dichloro-5-nitrofurans in Salmonella typhimurium. Environ. Mol. Mutagen. 25, 58-66.
9. IARC (1974). International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man, Vol. 7, Some Anti-Thyroid and Related Substances, Nitrofurans and Industrial Chemicals. IARC, Lyon, France.
10. Jones, E., Fox, V., Elliott, B. M., and Moore, N. P. (2001). The mutagenic potential of acetonitrile in the bone marrow and peripheral blood of the mouse. Mutagenesis 2, 151-154.
11. Jurado, J., and Pueyo, C. (1995). Role of classical nitroreductase and O-acetyltransferase on the mutagenicity of nifurtimox and eight derivatives in Salmonella typhimurium. Environ. Mol. Mutagen. 26, 86-93.
12. Krishna, G., and Hayashi, M. (2000). In vivo rodent micronucleus assay: protocol, conduct and data interpretation. Mutat. Res. 455, 155-166.
13. Krishna, G., Urda, G., and Paulissen, J. (2000). Historical vehicle and positive control micronucleus data in mice and rats. Mutat. Res. 453, 45-50.
14. McCalla, D. R. (1983). Mutagenicity of nitrofuran derivatives: Review. Environ. Mutagen. 5, 745-765.
15. Murthy, M. S. S., and Najaria, K. B. (1980). Deactivation of furyl furamide (AF-2) by rat-liver microsomes and its implication in short-term test for mutagenicity/carcinogenicity. Mutat. Res. 77, 127-134.
16. Ni, Y. C., Heflich, R. H., Kadlubar, F. F., and Fu, P. P. (1987). Mutagenicity of nitrofurans in Salmonella typhimurium TA98, TA98NR, and TA98/1,8-DNP6. Mutat. Res. 192, 15-22.
17. OECD (1997). Guideline 474, Mammalian Erythrocyte Micronucleus Test, OECD Guideline for the Testing of Chemicals, pp. 1-10. OECD, Paris, France.
18. Ramos, A., Vizoso, A., Edreira, A., Betancourt, J., and Decalo, M. (1997). Activity of nitroalkenederivative 1-(5-bromofur-2-il)-2-bromo-2-nitroethene in Salmonella/microsome assay and the mouse bone marrow micronucleus test. Mutat. Res. 390, 233-238.
19. Salamone, M. F., and Mavournin, K. H. (1994). Bone marrow micronucleus assay: A review of the mouse stocks used and their published mean spontaneous micronucleus frequencies. Environ. Mol. Mutagen. 23, 239-273.
20. Skeggs, H. R., Berglund, R. M., VandenHeuvel, W. J. A., Mrozik, H., Wislocki, P. G., and Wolf, F. J. (1984). Effect of liver enzymes on the mutagenicity of nitroheterocyclic compounds: Activation of 3a,4,5,6,7,7a-hexahydro-3-(1-methyl-5-nitro-1-H-imidazol-2-yl)-1,2-benzisoxazole and deactivation of nitrofurans and nitroimidazoles in the Ames test. Mutat. Res. 136, 1-8.
21. Slapsyte, G., Jankauskiene, A., Mierauskiene, J., and Lazutka, J. R. (2002). Cytogenetic analysis of peripheral blood lymphocytes of children treated with nitrofurantoin for recurrent urinary tract infection. Mutagenesis. 1, 31-35.
22. Sturdik, E., Rosenberg, M., Stibranyi, L., Balaz, S., Chreno, O., Ebringer, L., Ilavsky, D., and Vegh, D. (1985). Structure-mutagenicity relationships of 5-nitro-2-furylethylenes in Salmonella typhimurium TA 98. Chem. Biol. Interact. 53, 145-153.